Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hanley

Showing results (391-400 of 436) with videos related to

Pageof 44
Sort By:
The Lancet. Neurology|March 22, 2025
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trialIssam A Awad, Roberto J Alcazar-Felix, Agnieszka Stadnik, et al.
Fetal Diagnosis and Therapy|July 13, 2026
Fetal Echocardiography and Hyperoxia Testing after Serial Amnioinfusions: Results from the RAFT Trial Bilateral Renal Agenesis ArmMariam Taleb, Jena L Miller, Meredith A Atkinson, et al.
Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.
Neurology|December 23, 2021
Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III TrialsJessica R Magid-Bernstein, Yunke Li, Sung-Min Cho, et al.
Neurosurgery|March 21, 2019
Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) ProcedureIssam A Awad, Sean P Polster, Julián Carrión-Penagos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 5, 2019
A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III)Wendy C Ziai, Nichol McBee, Karen Lane, et al.
Stroke|August 6, 2015
Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR IIIAlastair J S Webb, Natalie L Ullman, Tim C Morgan, et al.
Journal of Clinical and Translational Science|July 3, 2023
Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation NetworkKaren Lane, Marisha E Palm, Eve Marion, et al.
Neurosurgery|November 27, 2018
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) TrialSean P Polster, Agnieszka Stadnik, Amy L Akers, et al.
JAMA|December 5, 2023
Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis: The Renal Anhydramnios Fetal Therapy TrialJena L Miller, Ahmet A Baschat, Mara Rosner, et al.
Pageof 44

Showing results (391-400 of 436) with videos related to

Sort By:
Pageof 44
The Lancet. Neurology|March 22, 2025
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trialIssam A Awad, Roberto J Alcazar-Felix, Agnieszka Stadnik, et al.
Fetal Diagnosis and Therapy|July 13, 2026
Fetal Echocardiography and Hyperoxia Testing after Serial Amnioinfusions: Results from the RAFT Trial Bilateral Renal Agenesis ArmMariam Taleb, Jena L Miller, Meredith A Atkinson, et al.
Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.
Neurology|December 23, 2021
Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III TrialsJessica R Magid-Bernstein, Yunke Li, Sung-Min Cho, et al.
Neurosurgery|March 21, 2019
Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) ProcedureIssam A Awad, Sean P Polster, Julián Carrión-Penagos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 5, 2019
A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III)Wendy C Ziai, Nichol McBee, Karen Lane, et al.
Stroke|August 6, 2015
Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR IIIAlastair J S Webb, Natalie L Ullman, Tim C Morgan, et al.
Journal of Clinical and Translational Science|July 3, 2023
Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation NetworkKaren Lane, Marisha E Palm, Eve Marion, et al.
Neurosurgery|November 27, 2018
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) TrialSean P Polster, Agnieszka Stadnik, Amy L Akers, et al.
JAMA|December 5, 2023
Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis: The Renal Anhydramnios Fetal Therapy TrialJena L Miller, Ahmet A Baschat, Mara Rosner, et al.
Pageof 44